137 related articles for article (PubMed ID: 27598273)
1. [Clinical and microbiological characteristics of complicated intra-abdominal infection in Colombia: a multicenter study].
Vallejo M; Cuesta DP; Flórez LE; Correa A; Llanos CE; Isaza B; Vanegas S; Osorio J; Casanova L; Villegas MV
Rev Chilena Infectol; 2016 Jun; 33(3):261-7. PubMed ID: 27598273
[TBL] [Abstract][Full Text] [Related]
2. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Morganti L; Córdova E; Cassini E; Gómez N; López Moral L; Badía M; Rodríguez C
Rev Esp Quimioter; 2016 Aug; 29(4):202-5. PubMed ID: 27318458
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study.
Jean SS; Ko WC; Xie Y; Pawar V; Zhang D; Prajapati G; Mendoza M; Kiratisin P; Ramalheira E; Castro AP; Rosso F; Hsueh PR
Int J Antimicrob Agents; 2014 Sep; 44(3):222-8. PubMed ID: 25106073
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections.
Chong YP; Bae IG; Lee SR; Chung JW; Jun JB; Choo EJ; Moon SY; Lee MS; Jeon MH; Song EH; Lee EJ; Park SY; Kim YS
PLoS One; 2015; 10(4):e0119956. PubMed ID: 25910171
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections.
Liu L; Ni Y
BMC Infect Dis; 2018 Nov; 18(1):584. PubMed ID: 30453893
[TBL] [Abstract][Full Text] [Related]
7. [Microbiological and resistance profiles of community acquired and nosocomial intra abdominal infections in surgery of National Hospital Guillermo Almenara, Lima, Peru].
Revoredo Rego F; Huamán Egoávil E; Zegarra Cavani S; Auris Mora H; Valderrama Barrientos R
Rev Gastroenterol Peru; 2016; 36(2):115-22. PubMed ID: 27409087
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.
Hawser S; Hoban DJ; Badal RE; Bouchillon SK; Biedenbach D; Hackel M; Morrissey I
J Chemother; 2015 Feb; 27(2):67-73. PubMed ID: 24548089
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
[TBL] [Abstract][Full Text] [Related]
10. Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: current experience in a teaching hospital.
Shree N; Arora BS; Mohil RS; Kasana D; Biswal I
Indian J Pathol Microbiol; 2013; 56(4):388-92. PubMed ID: 24441227
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological study of community- and hospital-acquired intraabdominal infections.
Zhang S; Huang W
Chin J Traumatol; 2015; 18(2):84-9. PubMed ID: 26511299
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Resistance in Community-Acquired Intra-Abdominal Infections: Diabetes Mellitus as a Risk Factor.
Núñez SA; Lacal V; Núñez J; Serruto G; Zárate MS; Verón MT
Surg Infect (Larchmt); 2020 Feb; 21(1):62-68. PubMed ID: 31441705
[No Abstract] [Full Text] [Related]
13. The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance.
Haddad N; Kanj SS; Awad LS; Abdallah DI; Moghnieh RA
BMC Infect Dis; 2019 Mar; 19(1):293. PubMed ID: 30925909
[TBL] [Abstract][Full Text] [Related]
14. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010.
Badal RE; Bouchillon SK; Lob SH; Hackel MA; Hawser SP; Hoban DJ
Pediatr Infect Dis J; 2013 Jun; 32(6):636-40. PubMed ID: 23838732
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.
Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hackel MA; Biedenbach DJ; Goff DA
J Infect; 2014 Jan; 68(1):71-6. PubMed ID: 24016768
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
Ouyang W; Xue H; Chen Y; Gao W; Li X; Wei J; Wen Z
Int J Antimicrob Agents; 2016 Mar; 47(3):210-6. PubMed ID: 26899413
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Microbiological Characteristics of Patients with Complicated Intra-abdominal Infections in Intensive Care Unit.
Xiong YM; Rao X
Curr Med Sci; 2020 Feb; 40(1):104-109. PubMed ID: 32166671
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis.
Grau S; Lozano V; Valladares A; Cavanillas R; Xie Y; Nocea G
Appl Health Econ Health Policy; 2015 Aug; 13(4):369-79. PubMed ID: 25761545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
